Back to Search
RONALD OUDIZ, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1316957228IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G70500(CA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 1989
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertension.
PMID 28090295·Pulm Circ·2016
8-other
Diagnosis and assessment of pulmonary arterial hypertension.
PMID 19555859·J Am Coll Cardiol·2009
6-review
End points and clinical trial design in pulmonary arterial hypertension.
PMID 19555863·J Am Coll Cardiol·2009
6-review
Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review.
PMID 19332188·Am Heart J·2009
6-review
Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension.
PMID 17707133·Eur J Heart Fail·2007
3-trial
Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.
PMID 16377296·Am J Cardiol·2006
4-observational
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
PMID 15302727·Chest·2004
3-trial
Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.
PMID 15249447·Chest·2004
8-other
Safety of EBCT contrast injection studies in severe pulmonary hypertension.
PMID 11215925·Int J Card Imaging·2000
8-other
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
PMID 18812445·Chest·2009
3-trial
Pulmonary hypertension associated with left-sided heart disease.
PMID 17338938·Clin Chest Med·2007
6-review
The role of exercise testing in the management of pulmonary arterial hypertension.
PMID 16121314·Semin Respir Crit Care Med·2005
6-review
Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
PMID 18506008·Circulation·2008
4-observational
Prevalence of obstructive coronary artery disease in an outpatient cardiac CT angiography environment.
PMID 17651836·Int J Cardiol·2008
4-observational
Serial hemodynamics and complications of pregnancy in severe pulmonary arterial hypertension.
PMID 17873487·Cardiology·2008
5-case
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
PMID 18094217·J Clin Pharmacol·2008
3-trial
Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases.
PMID 19015412·Circulation·2008
8-other
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
PMID 17472992·Ann Rheum Dis·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21840 NORMANDIE AVE, STE. 700
TORRANCE, CA 90502 - Phone
- (310) 222-5101
Quick Facts
- NPI
- 1316957228
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile